Farallon Capital Management LLC Inspire Medical Systems, Inc. Transaction History

Farallon Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$165.3 - $226.0 $37.7 Million - $51.6 Million	-228,242 Reduced 26.69%	626,854 $135 Million
Q4 2023 Feb 14, 2024	BUY	$125.26 - $203.83 $107 Million - $174 Million	855,096 New	855,096 $174 Million
Q3 2023 Nov 14, 2023	BUY	$185.0 - $326.08 $78.8 Million - $139 Million	426,096 New	426,096 $84.6 Million
Q2 2023 Aug 14, 2023	BUY	$226.52 - $324.64 $18.2 Million - $26.1 Million	80,500 Added 33.18%	323,096 $105 Million
Q4 2022 Feb 14, 2023	SELL	$164.02 - $259.76 $39.3 Million - $62.2 Million	-239,400 Reduced 49.67%	242,596 $61.1 Million
Q3 2022 Nov 14, 2022	BUY	$170.68 - $226.46 $11.8 Million - $15.6 Million	68,996 Added 16.71%	481,996 $85.5 Million
Q2 2022 Aug 15, 2022	BUY	$147.53 - $266.6 $19.1 Million - $34.5 Million	129,500 Added 45.68%	413,000 $75.4 Million
Q1 2022 May 16, 2022	BUY	$193.94 - $261.91 $55 Million - $74.3 Million	283,500 New	283,500 $72.8 Million

397

27.5M

519K

590K

Ticker INSP
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,788,600
Market Cap $5.34B
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.